Ovarian Cancer Epidemiology, Healthcare Access and Disparities Study (ORCHID)
In the United States, less than 40% of ovarian cancer patients receive the standard of care for surgery and chemotherapy. Black patients are even less likely to receive this care in comparison to their White counterparts. Racial differences in ovarian cancer care and outcomes is largely due to differences in healthcare access.
The purpose of our study is to evaluate the different dimensions of healthcare access among Black, White, and Hispanic study participants: availability, affordability, accessibility, accommodation and acceptability of health care services.
With the results of this study, we hope to better understand the nature of racial disparities, assess the importance of race-specific barriers to care, and find ways to address these barriers in order to improve ovarian cancer care for all patients.
ORCHiD Schema
The figure shows the schema for the ORCHiD study. For the study, we utilized focus groups and cognitive interviews to create a primary cohort pilot study and a secondary cohort of pre-existing data. We then assessed the HCA dimensions, socio-demographic/ epidemiological risk factors, and obtained biospecimens. We used these factors to determine if treatment met guidelines, and what survival outcomes were in each group.
